Vivani Medical director reports 99,010-share transaction
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Vivani Medical, Inc. director Aaron Mendelsohn reported an entry involving 99,010 common shares on November 18, 2026. Its transaction description calls it a private purchase at $1.01 per share, while the entry is classified as a grant/award acquisition and indicates a disposition, so the reported mechanics conflict. The post-entry holdings are listed as 997,327 indirectly and 168,170 directly held shares. No Rule 10b5-1 plan is reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F1, F2 | 99,010 | $1.01 | $100K |
| Holding | Common Stock | -- | -- | -- |
Footnotes (2)
- F1. The reporting person purchased 99,010 shares of the Issuer's common stock in a private sale transaction as disclosed in the Share Purchase Agreement dated as of November 15, 2026 at a price of $1.01 per share, which was the last reported sale price of the Issuers common stock on the Nasdaq on November 13, 2026 (the trading day immediately prior to November 15, 2026). The gross proceeds from this private sale transaction were $100,000.10. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in the transaction set forth in this footnote.
- F2. The reporting person owns 1,165,497 shares directly and/or indirectly as follows: (i) 168,170 shares of common stock owned by the reporting person, (ii) 150,930 shares in five trusts, each of which has been established for a separate grandchild of the Reporting Person, with each trust owning an aggregate of 30,186 shares of common stock, all trusts with the same terms, over which the Reporting Person has voting and dispositive authority, (iii) 846,397 shares of common stock owned by MFE, LLC over which the Reporting Person has voting and dispositive authority. The Reporting Person disclaims pecuniary interest in 20% of MFE, LLC and therefore disclaims 169,279 shares of the 846,397 shares of common stock owned by MFE, LLC, which 169,279 shares are beneficially owned by other members of the limited liability company.
Key Figures
Key Terms
dispositive authority regulatory
pecuniary interest regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.